From: Maxillofacial and neck trauma: a damage control approach
Tranexamic Acid | within 3Â h of injury loading dose 1Â g over 10Â min, followed by 1Â g over 8Â h |
Ionized Calcium Levels | maintain in normal ranges during MT |
Plasma : RBC | at least 1:2 (preferably 1:1) maintain Hb levels: 7–9 g/dl maintain coagulation parameters (repeated monitoring of PT, aPTT, fibrinogen levels, platelets count, viscoelastic testing) in normal ranges during MT |
Fibrinogen | 3–4 g administer in case of thromboelastometric signs of a functional fibrinogen deficit or a plasma fibrinogen level of less than 1.5 to 2 g/l |
Platelet Count | 50 × 109/l if ongoing bleeding and/or TBI: 100 × 109/l initial dose 4–8 single platelet units or 1 aphaeresis pack |
Blood Pressure | SBP: 80 to 90 mmHg until hemorrhage control (no TBI) if severe TBI (GCS ≤ 8) MAP ≥ 80 mmHg |
 | consider rFVIIa if major bleeding and traumatic coagulopathy persist despite maximal attempts to stop bleeding |
 | in case of pre-trauma therapeutic anticoagulation or antiplatelets drugs consider specific treatment (ex. desmopressin, PCC, etc) |